SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Oncothyreon
An SI Board Since September 1996
Posts SubjectMarks Bans Symbol
2344 74 0 ONTY
Emcee:  John Curtis Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2169Well it could be this afternoon or never. I sure don't know. I do know the Fgeneguru-5/21/2013
2168No doubt that the results are impressive. However, if Merck is convinced that tbmaz001-5/21/2013
2167Maz -- ONTY is a risky investment for sure. That being said -- I find the STARTgeneguru-5/21/2013
2166Steve, Is it realistic to expect the FDA to approve BLP25 based on the recentlybmaz00125/21/2013
2165So this would be what the average Joe/Jane would look like.... Concurrent: Vscaram(o)uche-5/20/2013
2164>> concurrent CRT demonstrated significant benefit in terms of response rascaram(o)uche-5/20/2013
2163Thanks, Ian. I too, have plenty of reservations with respect to the company.The Ox-5/19/2013
2162There are statisticians who are saying that this cut in the data is like blue eyscaram(o)uche-5/19/2013
2161>> Rationale for abiraterone trial given in prostate abstract. Cool. Part scaram(o)uche-5/18/2013
2160urrrrrrgggggghhhhhh..... that one stayed up through the edit period. Thoughscaram(o)uche-5/17/2013
2159Acute haematological toxicity grade 3/4 was more pronounced in the sequential (Sscaram(o)uche-5/17/2013
2158Not a pukin' chance that proximity of C to irradiation was a factor. Sorry. scaram(o)uche-5/17/2013
2157In its days as Biomira with a breast cancer vaccine, this company did a fabulousIan@SI25/17/2013
2156I agree. There is much more there than might be seen by an untrained eye.The Ox-5/17/2013
2155As you know, clinical trials are experiments..... they're experiments using scaram(o)uche-5/17/2013
2154Cool, thanks for the perspective. To me, it was a "gang up and distribute scaram(o)uche-5/17/2013
2153This statement stood out in my mind: In the concurrent chemo-radiation subgroup,The Ox-5/17/2013
2152Simply put, I think yesterday was more a "sell the news" event. SinceThe Ox-5/17/2013
2151Stayed away from Twitter today, to avoid having my nose rubbed in it. But took ascaram(o)uche-5/16/2013
2150Best Abstract of ASCO 2013 Show me a better one. Give me the abstract number. geneguru-5/16/2013
2149Thanks! Voiced this opinion, in a different thread.... <i>I want to be scaram(o)uche-5/16/2013
2148Just noticed this (FWIW): "...Cowen & Co. analyst Simos Simeonidis sainigel bates-5/16/2013
21472.06 filling now........scaram(o)uche-5/16/2013
2146set up lowball bids this morning, at 2.06 and 2.16. 2.16 just got a partial hit.scaram(o)uche-5/16/2013
2145schade..... finance.yahoo.com; (for some reason, I thought that they were huscaram(o)uche-5/15/2013
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News